Biosimilar bidding in centralized tenders in Norway

Our objective is to study the competition effect of biosimilar entry in centralized tenders for an expensive category or drugs - TNF-inhibitors. We use monthly observations of prices and volumes for all brands and biosimilars in this drug category in Norway, covering the period from Jan. 2006 to De...

Full description

Bibliographic Details
Main Authors: Dag Morten Dalen, Steinar Strøm, Marilena Locatelli
Format: Article
Language:English
Published: University of Oslo 2021-01-01
Series:Nordic Journal of Health Economics
Subjects:
Online Access:https://journals.uio.no/NJHE/article/view/7394